Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clínica de Intervención en Neurociencias (CIN) is a specialized medical and research institution based in Mexico City, focused on the diagnosis and advanced treatment of complex neurological and neurosurgical conditions. The clinic provides high-end clinical services, including minimally invasive neurosurgery, neuromodulation, and deep brain stimulation for patients with Parkinson's disease and refractory epilepsy. In addition to its clinical practice, CIN serves as a prominent clinical research site, collaborating with global pharmaceutical and biotech companies to conduct Phase II and III clinical trials. The center is recognized for integrating multidisciplinary neurological care with cutting-edge interventional technologies. Its expertise spans neuro-oncology, functional neurosurgery, and the management of degenerative spinal diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clínica de Intervención en Neurociencias.